# Amgen Inc. (AMGN) — Q3-2022 Earnings Results

**Report date:** 2022-11-03 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2022

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 1.16%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $4.70 | N/A | +6.17% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about future growth. They pointed to strong product performance while recognizing market challenges.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They acknowledged ongoing challenges in the market but expressed confidence in their pipeline.

> The team emphasized their commitment to innovation and patient access.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Amgen's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock fell by 1.16%, likely due to the lack of revenue data and guidance, which may have left investors uncertain about future performance. The cautious tone from management may have also contributed to the stock's decline.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2022_